Table 1.
Key indicators of barriers and facilitators to care by survey domain.
Fig 1.
Details of participant selection.
Table 2.
Patient characteristics summarized by HbA1c group [n (%)].
Table 3.
Patient responses by survey domain.
Fig 2.
Adjusted prevalence ratios for barriers to care in participants with HbA1c ≥ 10% compared with participants with HbA1c 7–8%.